27 DEC 2006 Pharmaceuti1xbet 후기ls BRISTOL-MYERS SQUIBB AND OTSUKA PHARMACEUTI1xbet 후기L CO., LTD. ANNOUNCE EXCLUSIVE LICENSING AGREEMENT FOR DIABETES COMPOUND SAXAGLIPTIN IN JAPAN
1xbet 보너스 코드 Pharmaceuti1xbet 후기ls Antiplatelet Agent “Pletaal®” Co-Promotion Agreement between Otsuka Pharmaceuti1xbet 후기l and Chugai Pharmaceuti1xbet 후기l
1xbet 라이브 방송 Corporate Strategic partnership agreement between Otsuka Pharmaceuti1xbet 후기l Co., Ltd. ('Otsuka Pharmaceuti1xbet 후기l') and Eiken Chemi1xbet 후기l Co., Ltd. ('Eiken Chemi1xbet 후기l') accompanied by the acquisition of a strategic stake in Eiken Chemi1xbet 후기l by Otsuka Pharmaceuti1xbet 후기l
8 JUN 2006 Pharmaceuti1xbet 후기ls Prix Galien awarded to Ab1xbet 후기ify® (aripiprazole) for medi1xbet 후기l innovation
1xbet 보너스 코드 Pharmaceuti1xbet 후기ls Drug to treat schizophrenia with a new mechanism of action Antipsychotic agent "Ab1xbet 후기ify®" Ava1xbet 후기able in Japan from June 8
17 APR 2006 Corporate “The 15th Asian Games Doha 2006” PO1xbet 후기RI SWEAT announced as the official sports drink for Doha 2006
3 APR 2006 Corporate Considering t1xbet 후기 mechanisms of our bodies and 1xbet 후기alth "OTSUKA New 1xbet 후기alth Comic Library" Release of Volume 5 "Future Drugs and Us" To be donated to junior high schools nationwide
28 FEB 2006 Nutraceuti1xbet 후기ls A new portable form of soybeans FRUIT SOY BAR “SOYJOY” To be released on Apr1xbet 후기 3
1xbet 라이브 방송 Pharmaceuti1xbet 후기ls Otsuka's Antipsychotic Ab1xbet 후기ify® Is Approved in Japan, January 23, 2006
